1. Amminger GP, Schafer MR, Papageorgiou K et al (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67:146–154
2. APA (2010) DSM-V development: proposed draft revisions to DSM disorders and criteria. http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx? rid = 412. Accessed 8 July 2010
3. Bechdolf A, Ruhrmann S, Wagner M et al (2005) Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment. British Journal of Psychiatry Suppl 48:s45–s48
4. Bechdolf A, Veith V, Vogeley K et al (2008) PREVENT: background and rational of a clinical study comparing the preventive effects of CBT, aripriprazole and placebo in persons at-risk for psychosis. Early Interv Psychiatry 2(Suppl 1):11
5. Berger G, Wood S, Ross M et al (2008) Neuroprotective effects of low dose lithium in individuals at ultra-high risk for psychosis. Early Interv Psychiatry 2:A28